Department of Obstetrics and Gynecology and Center for Androgen-Related Disorders, Cedars-Sinai Medical Center, 8635 West Third Street, Suite 160W, Los Angeles, California 90048, USA.
J Clin Endocrinol Metab. 2010 Feb;95(2):935-42. doi: 10.1210/jc.2009-1158. Epub 2010 Jan 20.
Adipose tissue dysfunction associated with low-grade chronic inflammation and dysregulation of adipokine secretion might significantly contribute to the pathogenesis of polycystic ovary syndrome (PCOS).
The objective of the study was to determine whether the effect of TNF-alpha, IL-6, monocyte chemoattractant protein-1, or coculture of adipocytes and adipose tissue macrophages (ATMs), on the secretion of adiponectin by adipocytes, differs in PCOS compared with controls.
Primary cultures of sc adipocytes and coculture of adipocytes and ATMs from overweight and obese patients with PCOS and healthy control women were used.
Adiponectin secretion by adipocytes was measured.
The baseline secretion of adiponectin by isolated adipocytes did not differ between PCOS and control samples. The net change in adiponectin secretion in response to IL-6, monocyte chemoattractant protein-1, and TNF-alpha differed between PCOS (decreasing) and control (increasing) adipocytes, although the difference reached significance only for TNF-alpha (P < 0.04). Coculture of isolated adipocytes and ATMs resulted in a decrease in adiponectin secretion by PCOS (P < 0.05) but not control adipocytes, and the difference between the net change in adiponectin secretion in PCOS vs. control samples was significant (P < 0.03).
Our results suggest that adiponectin secretion by adipocytes in response to cytokines/chemokines and most notably in response to coculturing with ATMs differs between PCOS and control women, favoring greater suppression of adiponectin in PCOS. The mechanisms underlying these defects and the role of concurrent obesity remain to be determined.
与低度慢性炎症和脂联素分泌失调相关的脂肪组织功能障碍可能对多囊卵巢综合征(PCOS)的发病机制有重要贡献。
本研究旨在确定脂肪细胞因子 TNF-α、IL-6、单核细胞趋化蛋白-1 或脂肪细胞与脂肪组织巨噬细胞(ATMs)的共培养对脂肪细胞脂联素分泌的影响,在 PCOS 患者中与对照组是否存在差异。
使用超重和肥胖的 PCOS 患者和健康对照女性的皮下脂肪细胞原代培养物和脂肪细胞与 ATMs 的共培养物。
脂肪细胞脂联素的分泌。
分离的脂肪细胞基础状态下脂联素的分泌在 PCOS 和对照组之间没有差异。对 IL-6、单核细胞趋化蛋白-1 和 TNF-α的反应中脂联素分泌的净变化在 PCOS(减少)和对照组(增加)脂肪细胞之间存在差异,尽管只有 TNF-α(P < 0.04)差异有统计学意义。分离的脂肪细胞和 ATMs 的共培养导致 PCOS 脂肪细胞脂联素分泌减少(P < 0.05),但对对照组脂肪细胞没有影响,且 PCOS 与对照组之间脂联素分泌净变化的差异有统计学意义(P < 0.03)。
我们的结果表明,脂肪细胞对细胞因子/趋化因子的反应以及特别是对与 ATMs 共培养时的脂联素分泌在 PCOS 和对照组女性之间存在差异,有利于 PCOS 中脂联素的更大抑制。这些缺陷的潜在机制和肥胖的并存作用仍有待确定。